Try our Advanced Search for more refined results
Order | Filed: May 19, 2022 | Entered: May 19, 2022 In Re In the Matter of the Ex Parte Application of Betapharm Arzneimittel GmbH
Other Statutory Actions | California Central
For Order re Discovery Matter
MINUTES (In Chambers): Order DENYING Petitioner's Motion for Order Designating Documents as Non-Confidential (Dkt. Nos. 25-26) by Magistrate Judge Alka Sagar: denying 25 Motion for Order. Petitioner's motion to treat Amgen's tablet forms as non-confidential is DENIED. Having reached this decision, the Court declines to address the parties' respective arguments about whether the tablet forms produced by Amgen were appropriately designated as "Confidential - for attorney's eyes only." (see document for further details) (hr)
Utility | Filed: May 18, 2022 | Entered: May 18, 2022 Lindis Biotech, GmbH v. Amgen Inc.
Patent | Delaware
- CORRECTING ENTRY
CORRECTING ENTRY: Docket entry regarding Stipulation at D.I. 24 has been corrected. (dlb)
Order | Filed: May 18, 2022 | Entered: May 18, 2022 Lindis Biotech, GmbH v. Amgen Inc.
Patent | Delaware
SO ORDERED D.I. 24 STIPULATION TO EXTEND TIME for Defendant to File a Reply in Support of its Motion to May 27, 2022. filed by Amgen Inc. Ordered by Judge Christopher J. Burke on 5/18/2022. (dlb)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS